X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (94) 94
ledipasvir/sofosbuvir (83) 83
humans (70) 70
hepatitis c virus (67) 67
hepatitis c (65) 65
sofosbuvir (60) 60
gastroenterology & hepatology (58) 58
ledipasvir-sofosbuvir (52) 52
ribavirin (52) 52
hepatitis c, chronic - drug therapy (47) 47
antiviral agents - therapeutic use (46) 46
hepatitis (39) 39
ledipasvir (39) 39
interferon (38) 38
hcv (36) 36
male (34) 34
female (33) 33
cirrhosis (32) 32
pharmacology & pharmacy (32) 32
middle aged (31) 31
genotype (27) 27
hepacivirus - genetics (27) 27
virus-infection (27) 27
genotype 1 infection (26) 26
liver (26) 26
benzimidazoles - therapeutic use (25) 25
fluorenes - therapeutic use (25) 25
infection (25) 25
treatment-naive (25) 25
treatment outcome (24) 24
health aspects (23) 23
infectious diseases (23) 23
uridine monophosphate - analogs & derivatives (22) 22
antiviral agents (21) 21
antiviral agents - administration & dosage (21) 21
genotypes (20) 20
hepacivirus - drug effects (20) 20
patients (20) 20
therapy (20) 20
united-states (20) 20
benzimidazoles - administration & dosage (19) 19
fluorenes - administration & dosage (19) 19
aged (18) 18
drug therapy, combination (18) 18
efficacy (18) 18
sustained virologic response (18) 18
care and treatment (17) 17
hepatitis c - drug therapy (17) 17
hepatitis c, chronic - virology (16) 16
infections (16) 16
open-label (16) 16
sustained virological response (16) 16
viruses (16) 16
adult (15) 15
analysis (15) 15
antiviral agents - adverse effects (15) 15
drug therapy (15) 15
hcv infection (15) 15
liver cirrhosis (15) 15
uridine monophosphate - therapeutic use (14) 14
benzimidazoles - adverse effects (13) 13
fluorenes - adverse effects (13) 13
prevalence (13) 13
sofosbuvir - therapeutic use (13) 13
direct-acting antivirals (12) 12
genetic aspects (12) 12
hepatology (12) 12
medical research (12) 12
uridine monophosphate - administration & dosage (12) 12
abridged index medicus (11) 11
genotype & phenotype (11) 11
hepatitis c, chronic - complications (11) 11
liver transplantation (11) 11
medicine, experimental (11) 11
regimens (11) 11
ribavirin - therapeutic use (11) 11
transplantation (11) 11
virology (11) 11
combination (10) 10
daclatasvir (10) 10
dasabuvir (10) 10
drug combinations (10) 10
fixed-dose combination (10) 10
immunology (10) 10
medicine & public health (10) 10
plus ribavirin (10) 10
retrospective studies (10) 10
ribavirin - administration & dosage (10) 10
safety (10) 10
simeprevir (10) 10
sofosbuvir - administration & dosage (10) 10
uridine monophosphate - adverse effects (10) 10
chronic hcv (9) 9
genotype 1 (9) 9
human immunodeficiency virus--hiv (9) 9
ritonavir (9) 9
treatment failure (9) 9
virus genotype 1 (9) 9
abt-450/r-ombitasvir (8) 8
biological response modifiers (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Gastroenterology, ISSN 0002-9270, 2018, Volume 114, Issue 2, pp. 185 - 188
Journal Article
Journal of Hepatology, ISSN 0168-8278, 04/2018, Volume 68, Issue 4, pp. 663 - 671
Ledipasvir/sofosbuvir (LDV/SOF) for 8 to 24 weeks is approved for the treatment of chronic hepatitis C virus infection (HCV). In the ION-3 study, 8 weeks of... 
8 week treatment | German Hepatitis C-Registry | Real-world | HCV genotype 1 | Ledipasvir/sofosbuvir | VIRUS-INFECTION | LEDIPASVIR-SOFOSBUVIR | GENOTYPE 1 INFECTION | HCV | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 2018, Volume 114, Issue 2, pp. 250 - 257
BACKGROUND:Data are sparse on treatment of chronic hepatitis C virus (HCV) in cancer patients. We evaluated the efficacy and safety of sofosbuvir-based therapy... 
PLUS RIBAVIRIN | LEDIPASVIR/SOFOSBUVIR | VELPATASVIR | REAL-WORLD | EFFICACY | HCV GENOTYPE 1 | SAFETY | DIRECT-ACTING ANTIVIRALS | GASTROENTEROLOGY & HEPATOLOGY | REGIMENS | LEDIPASVIR
Journal Article
Journal of Pharmacy Practice, ISSN 0897-1900, 4/2019, Volume 32, Issue 2, pp. 231 - 235
Sexual dysfunction is a bothersome side effect of several medications, though it has not yet been reported with the use of ledipasvir/sofosbuvir for the... 
hepatitis C virus | Harvoni | ledipasvir/sofosbuvir | sexual dysfunction
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 7, pp. 1599 - 1608
Journal Article
Hepatology, ISSN 0270-9139, 04/2018, Volume 67, Issue 4, pp. 1600 - 1608
The use of hepatitis C virus (HCV)‐positive organs in liver transplantation (LT) has increased in the era of direct‐acting antiviral therapy. A rising demand... 
UNITED-STATES | GENOTYPE 1 | LUNG TRANSPLANTATION | VIRUS-INFECTION | HEART-TRANSPLANTATION | SOFOSBUVIR PLUS RIBAVIRIN | HEROIN USE | LEDIPASVIR-SOFOSBUVIR | NATIONAL-HEALTH | NUTRITION EXAMINATION | GASTROENTEROLOGY & HEPATOLOGY | Epidemics | Hepatitis | Donors | Narcotics | Liver | Opioids | Overdose | Thorax | Hepatitis C | Liver transplantation | Kidney transplantation
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 04/2018, Volume 16, Issue 4, pp. 567 - 574.e6
Chronic infection with hepatitis C virus (HCV) has many hepatic and extrahepatic manifestations, measured by patient-reported outcomes (PROs). We measured... 
Fatigue | POLARIS-1 and POLARIS-4 | Work Productivity | Health Utility | Vitality | UNITED-STATES | LEDIPASVIR/SOFOSBUVIR REGIMENS | COST-EFFECTIVENESS | ECONOMIC-MODEL | CHRONIC LIVER-DISEASE | AND-3 CLINICAL-TRIALS | IMPACT | QUALITY-OF-LIFE | EXTRAHEPATIC MANIFESTATIONS | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Gastroenterology, ISSN 0016-5085, 01/2019, Volume 156, Issue 2, pp. 431 - 445
Chronic infection with hepatitis C virus is a major cause of liver disease and hepatocellular carcinoma worldwide. After the discovery of hepatitis C virus 3... 
Resistance | Direct-Acting Antivirals | Hepatitis C | Treatment Failure | LEDIPASVIR-SOFOSBUVIR | OPEN-LABEL | HCV INFECTION | INTERFERON-FREE | SUSTAINED VIROLOGICAL RESPONSE | GENOTYPE 1 | TREATMENT-NAIVE | PLUS SOFOSBUVIR | RESISTANCE-ASSOCIATED SUBSTITUTIONS | GASTROENTEROLOGY & HEPATOLOGY | MEDICAID REIMBURSEMENT
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 06/2018, Volume 47, Issue 11, pp. 1552 - 1553
Linked Content This article is linked to Modi et al paper. To view this article visit https://doi/org/10.1111/apt.14604. 
RESISTANCE | PHARMACOLOGY & PHARMACY | LEDIPASVIR/SOFOSBUVIR | GASTROENTEROLOGY & HEPATOLOGY | HCV INFECTION | SOFOSBUVIR | Retreatment | Simeprevir | Benzimidazoles | Humans | Fluorenes | Genotype | Antiviral Agents | Liver Cirrhosis | Hepatitis C, Chronic | Ribavirin | Sofosbuvir
Journal Article
Journal Article